المؤلفون: Nienke van de Kruis, Phyllis van der Ploeg, Jody H.C. Wilting, M. Caroline Vos, Anna M.J. Thijs, Joanne de Hullu, Petronella B. Ottevanger, Christianne Lok, Jurgen M.J. Piek

المصدر: Gynecologic Oncology Reports, Vol 42, Iss , Pp 101035- (2022)

مصطلحات موضوعية: Progression-free survival ratio, Growth-modulation index, Time to progression ratio, Ovarian carcinoma, Ovarian cancer, Gynecology and obstetrics, RG1-991, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2352578922001151Test; https://doaj.org/toc/2352-5789Test

الوصول الحر: https://doaj.org/article/81897c8e0e8b4228992aff841b0b5493Test

المؤلفون: Tirza Wouters, Jenny Soomers, Marieke Smink, Rixt A. Smit, Margreet Plaisier, Saskia Houterman, Ruud L. Bekkers, Angélique A. Schiffer, Victor J. Pop, Jurgen M.J. Piek

المصدر: Preventive Medicine Reports, Vol 13, Iss , Pp 238-243 (2019)

مصطلحات موضوعية: Medicine

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2211335519300014Test; https://doaj.org/toc/2211-3355Test

الوصول الحر: https://doaj.org/article/5f81ecaeb6844862abe432c5383fd207Test

المؤلفون: Tirza Wouters, Natasja Hendriks, Margot Koeneman, Arnold-Jan Kruse, Anna van de Sande, Heleen J. van Beekhuizen, Kees G. Gerestein, Ruud L.M. Bekkers, Jurgen M.J. Piek

المصدر: Case Reports in Women's Health, Vol 21, Iss , Pp - (2019)

مصطلحات موضوعية: Surgery, RD1-811, Gynecology and obstetrics, RG1-991

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2214911218301590Test; https://doaj.org/toc/2214-9112Test

الوصول الحر: https://doaj.org/article/e1a7bfc0c1874c17addc22d35cba48eaTest

المؤلفون: Bertine W. Huisman, Lisa Pagan, Rosanne G.C. Naafs, Wouter ten Voorde, Robert Rissmann, Jurgen M.J. Piek, Jeffrey Damman, Maria J. Juachon, Michelle Osse, Tessa Niemeyer-van der Kolk, Colette L.M. van Hees, Mariette I.E. van Poelgeest

المصدر: Journal of Lower Genital Tract Disease.

مصطلحات موضوعية: Obstetrics and Gynecology, General Medicine

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e51bab6ca9b2d6882276bb8b43757873Test
https://doi.org/10.1097/lgt.0000000000000731Test

المؤلفون: Natasja Hendriks, Margot M. Koeneman, Anna J.M. van de Sande, Charlotte G.J. Penders, Jurgen M.J. Piek, Loes F.S. Kooreman, Sander M.J. van Kuijk, Linde Hoosemans, Simone J.S. Sep, Peggy J. de Vos Van Steenwijk, Heleen J. van Beekhuizen, Brigitte F.M. Slangen, Hans W. Nijman, Roy F.P.M. Kruitwagen, Arnold-Jan Kruse

المساهمون: Translational Immunology Groningen (TRIGR), Targeted Gynaecologic Oncology (TARGON), Obstetrie & Gynaecologie, RS: GROW - R2 - Basic and Translational Cancer Biology, MUMC+: DA Pat Pathologie (9), MUMC+: KIO Kemta (9), RS: CAPHRI - R2 - Creating Value-Based Health Care, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie, MUMC+: MA Medische Staf Obstetrie Gynaecologie (9), MUMC+: MA Obstetrie Gynaecologie (3), MUMC+: Vrouw Moeder en Kind Centrum (3), MUMC+: MA Arts Assistenten Obstetrie Gynaecologie (9), MUMC+: MA Toegelatenen Obstetrie Gynaecologie (9), Surgery, Gynecological Oncology

المصدر: Journal of Immunotherapy, 45(3), 180-186. LIPPINCOTT WILLIAMS & WILKINS
Journal of Immunotherapy, 45(3), 180-186. Lippincott Williams & Wilkins

مصطلحات موضوعية: Male, Pharmacology, RISK, Cancer Research, HPV, LLETZ, Immunology, Uterine Cervical Neoplasms, Uterine Cervical Dysplasia, CANCER, imiquimod, Treatment Outcome, SDG 3 - Good Health and Well-being, Humans, Immunology and Allergy, Female, immunotherapy, CIN, RECURRENCE

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ab6d4404bf1601479e00e877143f083Test
https://research.rug.nl/en/publications/b30f18d4-5b23-41e8-8c3f-29676f7aac07Test

المؤلفون: Phyllis van der Ploeg, Cynthia Hendrikse, Anna Thijs, Hans M. Westgeest, Huberdina Smedts, Caroline Vos, Mathilde Jalving, C.A.R. Lok, Ingrid Boere, Maaike van Ham, Nelleke Ottevanger, Anneke M. Westermann, Constantijne Mom, Roy Lalisang, Sandrina Lambrechts, Ruud Bekkers, Jurgen M.J. Piek

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b25e4cd9661d105c9202a644f633997cTest
https://doi.org/10.2139/ssrn.4441215Test

المؤلفون: Jurgen M.J. Piek, Joanne A. de Hullu

المصدر: Context, Principles and Practice of TransGynecology ISBN: 9781108899987

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::fc5c9e6010541bb70f2dc3086e62dc41Test
https://doi.org/10.1017/9781108899987.024Test

المؤلفون: Ruud L.M. Bekkers, Phyllis van der Ploeg, Sandrina Lambrechts, Jurgen M.J. Piek, Hans M. Westgeest, Anna M.J. Thijs, Aniek Uittenboogaard, Anja van de Stolpe, Ingrid A. Boere

المساهمون: RS: GROW - R2 - Basic and Translational Cancer Biology, Obstetrie & Gynaecologie, MUMC+: MA Medische Staf Obstetrie Gynaecologie (9)

المصدر: Gynecologic Oncology, 163(2), 433-444. Elsevier Science

مصطلحات موضوعية: Oncology, medicine.medical_treatment, MULTICENTER, Targeted therapy, Phosphatidylinositol 3-Kinases, Clinical endpoint, 1ST-IN-HUMAN, Phosphoinositide-3 Kinase Inhibitors, Ovarian Neoplasms, Mammalian target of rapamycin, PI3K PATHWAY, TOR Serine-Threonine Kinases, MTOR, Obstetrics and Gynecology, MTOR Inhibitors, Signal transduction pathway, Temsirolimus, Treatment Outcome, PHASE-I, ADVANCED SOLID TUMORS, Biomarker (medicine), Female, TRIAL, medicine.drug, Signal Transduction, EPITHELIAL OVARIAN, medicine.medical_specialty, Clinical Decision-Making, Antineoplastic Agents, SDG 3 - Good Health and Well-being, Predictive Value of Tests, Ovarian cancer, Internal medicine, medicine, Biomarkers, Tumor, Humans, DOSE-ESCALATION, Protein kinase B, PI3K/AKT/mTOR pathway, Neoplasm Staging, business.industry, Patient Selection, Akt, medicine.disease, Clinical trial, Phosphatidylinositol-3-kinase, TEMSIROLIMUS, business, Proto-Oncogene Proteins c-akt

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1d4a86c00b11c2413b6be3b738bbee7Test
https://doi.org/10.1016/j.ygyno.2021.07.008Test

المؤلفون: Ronald P. Zweemer, Jurgen M.J. Piek, Joanna IntHout, Majke H.D. van Bommel, M. Caroline Vos, Rosella P.M.G. Hermens, Luc R.C.W. van Lonkhuijzen, Marline G. Harmsen, Mirjam J.A. Apperloo, Miranda P. Steenbeek, Marc van Beurden, José H.M. Keurentjes, Katja N. Gaarenstroom, Nicoline Hoogerbrugge, Monique M.A. Brood-van Zanten, Sjors F.P.J. Coppus, Charlotte G.J. Penders, Helena C. van Doorn, Joanne A. de Hullu

المساهمون: Faculteit Medische Wetenschappen/UMCG, Obstetrics and Gynaecology, CCA - Cancer Treatment and Quality of Life, Gynecological Oncology, RS: GROW - R2 - Basic and Translational Cancer Biology, MUMC+: CONC Patientenzorg OC (9), Obstetrics and gynaecology

المصدر: Gynecologic Oncology, 163(2), 371-377. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic oncology, 163(2), 371-377. Academic Press Inc.
Steenbeek, M P, van Bommel, M H D, Harmsen, M G, Hoogerbrugge, N, van Doorn, H C, Keurentjes, J H M, van Beurden, M, Zweemer, R P, Gaarenstroom, K N, Penders, C G J, Brood-van Zanten, M M A, Vos, M C, Piek, J M, van Lonkhuijzen, L R C W, Apperloo, M J A, Coppus, S F P J, IntHout, J, de Hullu, J A & Hermens, R P M G 2021, ' Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy ', Gynecologic Oncology, vol. 163, no. 2, pp. 371-377 . https://doi.org/10.1016/j.ygyno.2021.08.019Test
Gynecologic Oncology, 163, 2, pp. 371-377
Gynecologic Oncology, 163(2), 371-377. Academic Press
Gynecologic Oncology, 163(2), 371-377. Elsevier Science
Gynecologic Oncology, 163(2), 371-377. Academic Press Inc.
Gynecologic Oncology, 163, 371-377

مصطلحات موضوعية: Health Knowledge, Attitudes, Practice, medicine.medical_treatment, BRCA, Decisional conflict, Salpingectomy, Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14], RISK-REDUCING SURGERY, Prospective Studies, media_common, Ovarian Neoplasms, BRCA1 Protein, Obstetrics and Gynecology, WOMEN, Patient Preference, Prophylactic Surgical Procedures, ASSOCIATION, Middle Aged, Preference, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], Risk-reducing salpingo-oophorectomy, Oncology, BRCA1/2 MUTATION CARRIERS, Cohort, SURVIVAL, Female, Worry, Adult, medicine.medical_specialty, Heterozygote, media_common.quotation_subject, Ovariectomy, Decision Making, VALIDATION, Decision Support Techniques, All institutes and research themes of the Radboud University Medical Center, DISTRESS, SDG 3 - Good Health and Well-being, Ovarian cancer, medicine, Humans, BREAST-CANCER, Genetic Predisposition to Disease, SALPINGO-OOPHORECTOMY, BRCA2 Protein, business.industry, Oophorectomy, Cancer, medicine.disease, RANDOMIZED-TRIAL, Ovarian cancer prevention, Decision aid, Family medicine, Mutation, Feasibility Studies, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c22acf9acf2962a21cb516c5415e9965Test
http://www.scopus.com/inward/record.url?scp=85113744140&partnerID=8YFLogxKTest

المؤلفون: Glen R. Monroe, Hannah S. van Meurs, S. T. Paijens, Gijs van Haaften, Edith D.J. Peters, Ferdinando Sereno, Joline F. Roze, Hans W. Nijman, J. W. Groeneweg, Luc R.C.W. van Lonkhuijzen, Anna G.J. Brink, Ronald P. Zweemer, Jurgen M.J. Piek, Christianne A.R. Lok

المساهمون: Obstetrics and Gynaecology, CCA - Imaging and biomarkers, Translational Immunology Groningen (TRIGR), Targeted Gynaecologic Oncology (TARGON)

المصدر: Gynecologic oncology, 162(2), 413-420. Academic Press Inc.
Gynecologic Oncology, 162(2), 413-420. ACADEMIC PRESS INC ELSEVIER SCIENCE

مصطلحات موضوعية: Forkhead Box Protein L2, 0301 basic medicine, Mutant, Granulosa cell tumor, medicine.disease_cause, Circulating Tumor DNA, chemistry.chemical_compound, 0302 clinical medicine, Medicine, Digital polymerase chain reaction, Prospective Studies, Promoter Regions, Genetic, Telomerase, Aged, 80 and over, Ovarian Neoplasms, Mutation, ORIGIN, Obstetrics and Gynecology, Middle Aged, Oncology, 030220 oncology & carcinogenesis, Biomarker (medicine), Female, FOXL2, SERUM INHIBIN, TERT, 03 medical and health sciences, HORMONE, AGE, Biomarkers, Tumor, Humans, Tert promoter mutation, TERM-FOLLOW-UP, Aged, business.industry, INHIBIN-B, ctDNA, Biomarker, medicine.disease, Molecular biology, 030104 developmental biology, chemistry, MARKER, OVARY, Neoplasm Recurrence, Local, business, Ovarian cancer, DNA, Hormone

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b2b598d94e5a6a244c2f65ae9bd3ca4Test
https://research.rug.nl/en/publications/e55ba04f-bee6-4aa2-b53f-c586e71850f5Test